Insiders who have reported open-market trades at the same companies as Frederick G. Vogt. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Ryan D. Maynard - $503K in IOVA purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frederick G. Vogt is a corporate insider, tracked as Interim CEO & General Counsel, Director of IOVANCE BIOTHERAPEUTICS, INC. (IOVA). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Frederick G. Vogt submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Frederick G. Vogt is Interim CEO & General Counsel, Director of IOVANCE BIOTHERAPEUTICS, INC. (IOVA). 11 SEC Form 4 filings on record going back to 2024, most recently on 10 September 2026.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Frederick G. Vogt.
InsiderAlpha's records for Frederick G. Vogt go back to 2024: 11 primary Form 4 filings, an average of 3.7 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
